12.07.2015 Views

Corporate Magazine 2012 - Boehringer Ingelheim

Corporate Magazine 2012 - Boehringer Ingelheim

Corporate Magazine 2012 - Boehringer Ingelheim

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Leg vein healthUnder the brand name antistax®, <strong>Boehringer</strong> <strong>Ingelheim</strong>markets a range of products developed for the preventionand treatment of symptoms attributable toknown venous insufficiency. The most common symptomsof venous insufficiency observable for consumersare varicose veins, oedema of the lower leg, heavy ortired legs, sensation of tension, tingling, cramps andpain. antistax® capsules and tablets are scientificallyproven to help maintain healthy leg vein circulation.Heavy, aching and tired legs often occur after long periodsof standing or sitting, and increase at the end of theday or during the summer when outdoor temperaturesrise. antistax® tablets and antistax® capsules offer effectivetreatment of the described symptoms. antistax®helps to keep the fluid that flows out of the small venousvessels (venules) into the surrounding tissue atnormal levels, even when standing or sitting for a longtime.Red vine leaf extract, the active ingredient in antistax®products, has an antiinflammatory effect and works onthe endothelium inside the venules by sealing themfrom the inside, thereby reducing the swelling and thesensation of pain and heaviness.Products available in the antistax® range includeantistax® tablets, antistax® capsules and antistax®creme, as well as the cosmetic product antistax® legchilling gel.PainThe brand thomapyrin® comprises products for thetreatment of acute pain of mild to intermediate intensity.thomapyrin® classic is the core product, which iscomposed of a triple combination of acetylsalicylic acid,paracetamol and caffeine. The three components suppresspain synergistically via interaction with several pain-relatedmolecular mechanisms. As a result, thomapyrin®classic offers faster and superior efficacy comparedwith its single components which is, amongst others,well proven by state-of-the-art clinical studies.For this reason, the triple combination is recommendedby many national and international medical societies asfirst choice acute treatment for tension-type headachesand migraines. thomapyrin® is positioned as the experttreatment for headaches. Several line extensions areavailable: thomapyrin® classic for normal headache,thomapyrin® intensiv for stronger headache,thomapyrin® medium for milder headache, andthomapyrin® effervescent tablets as a galenic alternative.Alongside thomapyrin®, <strong>Boehringer</strong> <strong>Ingelheim</strong> also offersanalgesics in a combination of ibuprofen, allylisopropylacetylurea,dehydrated caffeine and magnesiumoxide in Japan and South Korea under the tradenameeve®, and as a mono active ingredient with metamizolin Brazil under the tradename anador®.86<strong>Boehringer</strong> <strong>Ingelheim</strong> annual report <strong>2012</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!